Related Experiment Video
Updated: May 18, 2026

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
Putative role of an ABC transporter in Fonsecaea pedrosoi multidrug resistance
Luciana P Rangel1, Otacílio C Moreira, Gustavo N Livramento
1Departamento de Microbiologia Geral, Laboratório de Bioquímica Microbiana/IMPPG, CCS, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho 373, Cidade Universitária, CEP 21941902, Rio de Janeiro, Brazil.
Abstract:
Fonsecaea pedrosoi, a dematiaceous fungus, is the main agent responsible for chromoblastomycosis, a chronic and progressive mycosis of the skin and subcutaneous tissues. This disease can cause different types of lesions depending on the immune status of the host. Its treatment is complicated by the toxicity of available antifungal agents as well as drug resistance. In this work, an ATP-binding cassette (ABC) transporter in this fungus was characterised, with the degree of expression related to the drug resistance of two strains (a patient isolated strain and a laboratory strain). A 150 kDa protein was detected by western blotting. The ATPase activity of membrane preparations was also evaluated. The F. pedrosoi transporter appears to behave like Pdr5p, a well-studied multidrug resistance transporter in Saccharomyces cerevisiae with the ability to hydrolyse different triphosphate nucleotides, as well as its response to classical inhibitors tested. Finally, a reverse transcription polymerase chain reaction (RT-PCR) approach was used and a 400 bp product was detected, corresponding to the highly conserved ATP-binding domain of ABC transporters. We suggest that an ABC transporter must be involved in F. pedrosoi multidrug resistance, and a complete understanding of this protein could bring an important contribution to antifungal treatment of this disease.
Insights
This study characterizes an ATP-binding cassette (ABC) transporter in Fonsecaea pedrosoi, linking its expression to drug resistance in chromoblastomycosis treatment. Understanding this transporter is crucial for developing new antifungal therapies.
Area of Science:
- Medical Mycology
- Molecular Biology
- Biochemistry
Background:
- Chromoblastomycosis, caused by Fonsecaea pedrosoi, is a chronic fungal infection characterized by skin and subcutaneous lesions.
- Treatment is challenging due to antifungal drug toxicity and emerging resistance.
- ATP-binding cassette (ABC) transporters are implicated in multidrug resistance across various organisms.
Purpose of the Study:
- To characterize an ATP-binding cassette (ABC) transporter in Fonsecaea pedrosoi.
- To investigate the relationship between ABC transporter expression and drug resistance in F. pedrosoi.
- To explore the potential of this transporter as a target for novel antifungal strategies.
Main Methods:
- Western blotting to detect a 150 kDa protein.
- ATPase activity assays on membrane preparations.
- Reverse transcription polymerase chain reaction (RT-PCR) to detect the ATP-binding domain.
Main Results:
- A 150 kDa protein, likely an ABC transporter, was detected.
- The transporter exhibited ATPase activity and responded to classical inhibitors, similar to Saccharomyces cerevisiae Pdr5p.
- RT-PCR confirmed the presence of a conserved ATP-binding domain (400 bp product).
- Higher expression of the ABC transporter correlated with increased drug resistance in F. pedrosoi strains.
Conclusions:
- An ABC transporter is involved in Fonsecaea pedrosoi multidrug resistance.
- Characterization of this ABC transporter provides insights into fungal drug resistance mechanisms.
- Further understanding of this protein could significantly contribute to improving antifungal treatments for chromoblastomycosis.
More Related Videos
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Development of Antibiotic Resistance
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...

